238 related articles for article (PubMed ID: 16908766)
1. Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia.
di Barletta MR; Viatchenko-Karpinski S; Nori A; Memmi M; Terentyev D; Turcato F; Valle G; Rizzi N; Napolitano C; Gyorke S; Volpe P; Priori SG
Circulation; 2006 Sep; 114(10):1012-9. PubMed ID: 16908766
[TBL] [Abstract][Full Text] [Related]
2. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin.
Viatchenko-Karpinski S; Terentyev D; Györke I; Terentyeva R; Volpe P; Priori SG; Napolitano C; Nori A; Williams SC; Györke S
Circ Res; 2004 Mar; 94(4):471-7. PubMed ID: 14715535
[TBL] [Abstract][Full Text] [Related]
3. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death.
Terentyev D; Nori A; Santoro M; Viatchenko-Karpinski S; Kubalova Z; Gyorke I; Terentyeva R; Vedamoorthyrao S; Blom NA; Valle G; Napolitano C; Williams SC; Volpe P; Priori SG; Gyorke S
Circ Res; 2006 May; 98(9):1151-8. PubMed ID: 16601229
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.
Lodola F; Morone D; Denegri M; Bongianino R; Nakahama H; Rutigliano L; Gosetti R; Rizzo G; Vollero A; Buonocore M; Napolitano C; Condorelli G; Priori SG; Di Pasquale E
Cell Death Dis; 2016 Oct; 7(10):e2393. PubMed ID: 27711080
[TBL] [Abstract][Full Text] [Related]
5. Catecholaminergic polymorphic ventricular tachycardia-related mutations R33Q and L167H alter calcium sensitivity of human cardiac calsequestrin.
Valle G; Galla D; Nori A; Priori SG; Gyorke S; de Filippis V; Volpe P
Biochem J; 2008 Jul; 413(2):291-303. PubMed ID: 18399795
[TBL] [Abstract][Full Text] [Related]
6. Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia.
Faggioni M; Kryshtal DO; Knollmann BC
Pediatr Cardiol; 2012 Aug; 33(6):959-67. PubMed ID: 22421959
[TBL] [Abstract][Full Text] [Related]
7. Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.
Song L; Alcalai R; Arad M; Wolf CM; Toka O; Conner DA; Berul CI; Eldar M; Seidman CE; Seidman JG
J Clin Invest; 2007 Jul; 117(7):1814-23. PubMed ID: 17607358
[TBL] [Abstract][Full Text] [Related]
8. Modulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac death.
Terentyev D; Kubalova Z; Valle G; Nori A; Vedamoorthyrao S; Terentyeva R; Viatchenko-Karpinski S; Bers DM; Williams SC; Volpe P; Gyorke S
Biophys J; 2008 Aug; 95(4):2037-48. PubMed ID: 18469084
[TBL] [Abstract][Full Text] [Related]
9. Compound heterozygous CASQ2 mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia.
Josephs K; Patel K; Janson CM; Montagna C; McDonald TV
Mol Genet Genomic Med; 2017 Nov; 5(6):788-794. PubMed ID: 29178653
[TBL] [Abstract][Full Text] [Related]
10. A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.
Dirksen WP; Lacombe VA; Chi M; Kalyanasundaram A; Viatchenko-Karpinski S; Terentyev D; Zhou Z; Vedamoorthyrao S; Li N; Chiamvimonvat N; Carnes CA; Franzini-Armstrong C; Györke S; Periasamy M
Cardiovasc Res; 2007 Jul; 75(1):69-78. PubMed ID: 17449018
[TBL] [Abstract][Full Text] [Related]
11. A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.
Gray B; Bagnall RD; Lam L; Ingles J; Turner C; Haan E; Davis A; Yang PC; Clancy CE; Sy RW; Semsarian C
Heart Rhythm; 2016 Aug; 13(8):1652-60. PubMed ID: 27157848
[TBL] [Abstract][Full Text] [Related]
12. Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.
Chopra N; Kannankeril PJ; Yang T; Hlaing T; Holinstat I; Ettensohn K; Pfeifer K; Akin B; Jones LR; Franzini-Armstrong C; Knollmann BC
Circ Res; 2007 Sep; 101(6):617-26. PubMed ID: 17656677
[TBL] [Abstract][Full Text] [Related]
13. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling.
Kirchhefer U; Wehrmeister D; Postma AV; Pohlentz G; Mormann M; Kucerova D; Müller FU; Schmitz W; Schulze-Bahr E; Wilde AA; Neumann J
J Mol Cell Cardiol; 2010 Jul; 49(1):95-105. PubMed ID: 20302875
[TBL] [Abstract][Full Text] [Related]
14. The cardiac ryanodine receptor luminal Ca2+ sensor governs Ca2+ waves, ventricular tachyarrhythmias and cardiac hypertrophy in calsequestrin-null mice.
Zhang J; Chen B; Zhong X; Mi T; Guo A; Zhou Q; Tan Z; Wu G; Chen AW; Fill M; Song LS; Chen SR
Biochem J; 2014 Jul; 461(1):99-106. PubMed ID: 24758151
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytosolic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes.
Kubalova Z; Györke I; Terentyeva R; Viatchenko-Karpinski S; Terentyev D; Williams SC; Györke S
J Physiol; 2004 Dec; 561(Pt 2):515-24. PubMed ID: 15486014
[TBL] [Abstract][Full Text] [Related]
16. Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants.
Bal NC; Jena N; Sopariwala D; Balaraju T; Shaikh S; Bal C; Sharon A; Gyorke S; Periasamy M
Biochem J; 2011 Apr; 435(2):391-9. PubMed ID: 21265816
[TBL] [Abstract][Full Text] [Related]
17. CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia.
Li Q; Guo R; Gao L; Cui L; Zhao Z; Yu X; Yuan Y; Xu X
Mol Genet Genomic Med; 2019 Nov; 7(11):e949. PubMed ID: 31482657
[TBL] [Abstract][Full Text] [Related]
18. Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.
Alcalai R; Wakimoto H; Arad M; Planer D; Konno T; Wang L; Seidman JG; Seidman CE; Berul CI
J Cardiovasc Electrophysiol; 2011 Mar; 22(3):316-24. PubMed ID: 20807279
[TBL] [Abstract][Full Text] [Related]
19. Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants.
Valle G; Arad M; Volpe P
J Muscle Res Cell Motil; 2020 Sep; 41(2-3):251-258. PubMed ID: 32902830
[TBL] [Abstract][Full Text] [Related]
20. Calsequestrin mutation and catecholaminergic polymorphic ventricular tachycardia: a simulation study of cellular mechanism.
Faber GM; Rudy Y
Cardiovasc Res; 2007 Jul; 75(1):79-88. PubMed ID: 17531962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]